Technical Analysis for NURO - NeuroMetrix, Inc.

Grade Last Price % Change Price Change
grade C 1.07 -1.83% -0.02
NURO closed down 1.83 percent on Friday, March 22, 2019, on 64 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Down
See historical NURO trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 21 20 DMA Support Bullish -1.83%
Mar 21 Outside Day Range Expansion -1.83%
Mar 20 Crossed Above 20 DMA Bullish -4.46%
Mar 20 180 Bullish Setup Bullish Swing Setup -4.46%
Mar 19 20 DMA Resistance Bearish 1.90%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.90%
Mar 18 20 DMA Resistance Bearish 0.94%

Older signals for NURO ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NeuroMetrix, Inc., a medical device company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with carpal tunnel syndrome, lumbosacral disc disease, spinal stenosis, and diabetes. The company focuses on the diagnosis and treatment of neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care; SENSUS pain therapy device, a transcutaneous electrical nerve stimulator used for chronic and intractable pain relief; and ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the assesment of CTS, low back and leg pain, and DPN, as well as consumables and accessories. The company is also developing SENTINEL device that provides sensory enhancement in the feet targeted at patients who have lost sensory perception in the lower extremities. NeuroMetrix, Inc. distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, hospitals, managed care organizations, retail health businesses, and independent distributors consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology and podiatry markets primarily in the United States, the United Kingdom, the Netherlands, and India. The company was founded in 1996 and is headquartered in Waltham, Massachusetts.
Medicine Pain Diabetes Pain Management Neuroscience Nervous System Neuromodulation Neurophysiology Neurotechnology Electrodiagnosis Acute Pain Carpal Tunnel Syndrome Diabetic Peripheral Neuropathy Transcutaneous Electrical Nerve Stimulation
Is NURO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.89
52 Week Low 0.6
Average Volume 119,586
200-Day Moving Average 1.1359
50-Day Moving Average 1.0487
20-Day Moving Average 1.087
10-Day Moving Average 1.099
Average True Range 0.0645
ADX 28.81
+DI 18.6111
-DI 11.1578
Chandelier Exit (Long, 3 ATRs ) 1.0065
Chandelier Exit (Short, 3 ATRs ) 1.1735
Upper Bollinger Band 1.1629
Lower Bollinger Band 1.0111
Percent B (%b) 0.39
BandWidth 13.965041
MACD Line 0.0204
MACD Signal Line 0.0269
MACD Histogram -0.0065
Fundamentals Value
Market Cap 1.99 Million
Num Shares 1.86 Million
EPS -19.02
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.21
Price-to-Book 0.63
PEG Ratio -0.01
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.12
Resistance 3 (R3) 1.12 1.10 1.11
Resistance 2 (R2) 1.10 1.09 1.10 1.10
Resistance 1 (R1) 1.09 1.08 1.08 1.09 1.10
Pivot Point 1.07 1.07 1.07 1.07 1.07
Support 1 (S1) 1.06 1.06 1.05 1.06 1.04
Support 2 (S2) 1.04 1.05 1.04 1.04
Support 3 (S3) 1.03 1.04 1.03
Support 4 (S4) 1.03